Doug Drysdale is the founder of Cybin. He has led Cybin through multiple clinical trials, including Phase 2 results for its psilocybin analog CYB3.
Doug Drysdale is the Co-founder and CEO of Cybin, a biopharmaceutical company developing psychedelic-based medicines for mental health conditions. He has led Cybin through multiple clinical trials, including Phase 2 results for its psilocybin analog CYB3. Drysdale previously served as Corporate Director at BetterLife Pharma.
Full founder directory · Investor directory · Company funding database · Fundraising library